Founder’s Insider Sale at SciSparc Raises Short-Term Outlook QuestionsFounder sells 462 SciSparc shares at $10, above market $8.73, amid 85% YTD drop—what it signals for the biotech’s future.SCISPARC LTD Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 03/06/2026, 14:16 3 minutes to read
